INSIGHTS ON DRUG DEVELOPMENT

  • The Organ-Chip Portfolio

    Watch to learn about an organ-chip that has been designed to reduce drug absorption while improving biological modeling to provide researchers with enhanced accuracy in forecasting human drug response.

  • Ultra-Low Cross-Linked Microgel Purification

    ULC microgel purification is often slowed by linear polymer contamination and limitations of centrifugation. Explore how hollow fiber TFF improves filtration efficiency and supports scalable processing.

  • Automation Of 3D Intestinal Organoids Culture

    Gain insight into how 3D organoids promise better disease modeling and drug screening and how challenges like assay complexity, reproducibility, and scalability hinder their widespread adoption in drug discovery.

  • Matrigel Dome Assay And Drug Screening Of Colorectal Cancer Organoids

    Using CRC organoids and bioprinting, explore the automation of dome assays to evaluate drug responses and delve into the insights from image-based end-point assays on the efficacy of anti-cancer treatments.

DRUG DEVELOPMENT SOLUTIONS

  • Our platform improves bioavailability, enables higher drug loads, optimizes delivery routes, and enhances formulation performance for small and large molecules across diverse therapeutic applications.

  • Uniquely Ergonomic System Microscopes With Intelligent Automation Leica DM3000 LED

    Enhance Laboratory Workflow

    The Leica DM3000 LED microscopes for pathology, cytology, haematology and many other applications feature a motorized nosepiece, condenser head, automated light intensity adjustment, and optional foot pedal. These intuitive microscopes improve workflows significantly. For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) like in-vitro-fertilization (IVF).

  • Curia was the first CRO to provide contract medicinal chemistry services to the pharmaceutical industry.

  • Curia’s DMPK scientists deliver expert solutions for your drug discovery programs. Providing bioanalytical methods development, in vitro ADMET testing and in vivo PK and PD services that span all stages of drug discovery up to candidate selection.

  • Guided by Quality by Design (QbD) principles, our experienced scientists develop tailored strategies that optimize product performance, manufacturability, stability, and regulatory readiness across all stages of development.